Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab + PPV for Diabetic TRD
NCT00690768Phase 2Completed
- Sponsor
- Universidade de São Paulo
- Start
- Mar 2008
- Primary completion
- May 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in Tractional retinal detachment (TRD), sponsored by Universidade de São Paulo. Started Mar 2008; status: completed.
02
Drugs
bevacizumab
03
Conditions
Tractional retinal detachment (TRD)
Beyond the preview
Go deeper on NCT00690768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00690768.